• Cefoperazone Sodium Salt: β-Lactamase-Stable Activity Profil

  2026-07-28

  Cefoperazone sodium salt is a semisynthetic cephalosporin antibiotic with robust antibacterial activity against gram-negative bacilli and high resistance to β-lactamase hydrolysis. It demonstrates low MIC values in vitro and is used extensively in research models of bacterial infection and antibiotic resistance.

• MLN8237 (Alisertib): Precision Targeting of Aurora A in Canc

  2026-07-28

  Explore how MLN8237 (Alisertib), a selective Aurora A kinase inhibitor, advances cancer biology by enabling high-specificity dissection of mitotic mechanisms and apoptosis in tumor cells. This article delivers a unique, protocol-rich perspective grounded in cutting-edge assay innovations.

• Comparative Antibacterial Profiles of β-Lactams: Insights fr

  2026-07-27

  Cullmann et al. conducted a landmark study comparing the antibacterial activity of N-formimidoyl thienamycin (MK0787) with several advanced β-lactam antibiotics, including cefoperazone, across a diverse panel of drug-resistant clinical isolates. The findings clarify spectrum strengths, β-lactamase stability, and bactericidal behavior among modern cephalosporins and carbapenems, informing researchers’ choices for resistance modeling and antimicrobial assay design.

• Cardiogreen (Indocyanine Green): Applied Protocols and Innov

  2026-07-27

  Cardiogreen (Indocyanine Green) stands apart as a vascular imaging dye and photosensitizer, enabling both high-fidelity diagnostics and advanced photodynamic therapy. This article unpacks protocol-level guidance, troubleshooting, and recent breakthroughs in leveraging Cardiogreen for quantitative measurement and immuno-oncology.

• Hexetidine (NSC-17764): Mechanistic Insights and Clinical Tr

  2026-07-26

  Explore the multifaceted antimicrobial actions of Hexetidine (NSC-17764), including its mechanistic underpinnings and critical assay considerations. Gain unique insights into how surface interactions and environmental factors impact its efficacy in oral infection management.

• CXCL1-CXCR2 Signaling Drives Microglial Activation in Pancre

  2026-07-25

  This study elucidates how CXCL1-CXCR2 signaling within the nucleus tractus solitarii (NTS) orchestrates microglial activation, directly contributing to the pathogenesis of pancreatic cancer-induced pain. By integrating transcriptomic, pharmacological, and behavioral approaches, the research identifies a central neuro-immune mechanism with substantial implications for targeted pain therapies.

• Modeling Ceftolozane Resistance in P. aeruginosa via ampC/am

  2026-07-24

  This reference study employs semi-mechanistic PK/PD modeling to quantify how specific ampC and ampD mutations drive ceftolozane-tazobactam resistance and adaptive responses in Pseudomonas aeruginosa. The findings clarify mutation-specific effects on drug efficacy, supporting more precise experimental designs and resistance surveillance strategies.

• Applied Workflows with mCherry mRNA: From Stability to Signa

  2026-07-24

  EZ Cap™ mCherry mRNA (5mCTP, ψUTP) empowers researchers with robust, immune-evasive red fluorescent protein expression. This article translates recent advances in nanoparticle delivery and mRNA engineering into actionable protocols and troubleshooting strategies for molecular tracking, reporter assays, and beyond.

• Multiomics Reveals Bifendate’s Mechanisms in Acute Liver Inj

  2026-07-23

  This study employs a multiomics approach to dissect the molecular mechanisms by which bifendate (DDB) and muaddil sapra treat acute liver injury. The findings highlight bifendate’s specific modulation of ncRNAs and immune-related proteins, providing a deeper understanding of its hepatoprotective action and guiding future clinical and experimental applications.

• Cefiderocol Efficacy Against Resistant Gram-Negative Isolate

  2026-07-23

  This study provides the first large-scale, direct comparison of cefiderocol and multiple β-lactam/β-lactamase inhibitor combinations against European Pseudomonas aeruginosa and Acinetobacter spp., including multidrug-resistant isolates. Findings demonstrate cefiderocol’s superior in vitro activity, informing antibiotic stewardship and susceptibility testing protocols for challenging Gram-negative pathogens.

• Noncompetitive Inhibition of Human PON1 by Phenytoin and AED

  2026-07-22

  This study by Beydemir et al. systematically investigates how widely used anti-epileptic drugs—including phenytoin (5,5-diphenylimidazolidine-2,4-dione)—noncompetitively inhibit human serum paraoxonase-1 (PON1) in vitro. The results establish quantitative inhibition constants, illuminating a potential mechanism for metabolic side effects in epilepsy therapy and providing a robust protocol for enzyme-drug interaction assays.

• Photothermal Therapy and CD47 Blockade Synergy in OSCC

  2026-07-22

  A recent study demonstrates that photothermal therapy (PTT) can significantly enhance the anti-tumor efficacy of CD47 blockade in oral squamous cell carcinoma (OSCC) by inducing immunogenic cell death and altering the tumor extracellular matrix. These findings provide a mechanistic basis for overcoming immune evasion and improving therapeutic responses in solid tumors.

• Antifungal Imidazoles Target CpAdhE in Cryptosporidium parvu

  2026-07-21

  The referenced study identifies antifungal imidazoles as potent inhibitors of the bifunctional aldehyde/alcohol dehydrogenase (CpAdhE) in Cryptosporidium parvum, a key metabolic enzyme in this zoonotic parasite. These findings support CpAdhE as a promising drug target and demonstrate the value of targeted compound screening for anti-cryptosporidial therapy development.

• GLI2 Drives Tumor Immune Evasion via WNT and Prostaglandin P

  2026-07-21

  This study identifies GLI2 as a central transcriptional regulator orchestrating tumor immune evasion and resistance to immune checkpoint blockade through coordinated WNT ligand production and prostaglandin signaling. These findings provide a mechanistic rationale for targeting GLI2-mediated transcription to overcome immunotherapeutic resistance in advanced cancers.

• Transmission Dynamics of Carbapenemase Genes in CREC, Guangd

  2026-07-20

  Chen et al. (2025) provide a detailed molecular epidemiological analysis of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong. The study reveals a high prevalence of multidrug resistance, especially involving plasmid-mediated blaNDM-1, and demonstrates efficient horizontal gene transfer, highlighting significant challenges for infection control and research on Gram-negative pathogens.

15313 records 1/1021 page Next 12345 下5页 Last page